Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 581 (miR-581) is a small non-coding RNA (18–24 nucleotides) belonging to the microRNA family, functioning mainly in the regulation of gene expression at the post-transcriptional level. It acts by binding to complementary sequences on target mRNAs, leading to mRNA degradation or inhibition of translation, and is a component of the larger regulatory system maintaining cellular homeostasis. miR-581 has been reported to function as a tumor suppressor in some cancers (e.g., hepatocellular carcinoma, prostate cancer), with its down-regulation associated with increased tumorigenesis. In gastric cancer, genetic variants affecting miR-581's interaction with the MUC4 gene may influence cancer risk and progression. Additionally, changes in miR-581 plasma levels have been associated with neurological recovery after stroke. Direct targeting by drugs is currently not reported, and its therapeutic utility remains largely investigational.
Binds to target mRNAs leading to translational repression or degradation; Direct interaction with target genes through RNA-induced silencing complexes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 581 (miR-581).